Education
About Us
Working with TipRanks
Follow Us
Qilian International Holding Group Limited (BGM)
NASDAQ:BGM
BGM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.70 - $14.78
Previous Close$12.71
Volume74.11K
Average Volume (3M)19.57K
Market Cap
$1.10B
Enterprise Value$898.52K
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)4.62M
Price to Earnings (P/E)―
Beta-0.25
Next EarningsN/A
EPS EstimateN/A
Last Dividend Ex-Date
Feb 27, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding77,222,140
10 Day Avg. Volume43,294
30 Day Avg. Volume19,569
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)42.57
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Qilian International Holding Group Limited News
PremiumCompany Announcements
BGM Group Completes Acquisition of Patriton Limited
PremiumCompany Announcements
BGM Group Acquires YX to Boost AI Strategy
PremiumCompany Announcements
BGM Group Ltd Announces Board Changes with New Leadership Appointments
---
Ownership Overview
―
Insiders
<0.01%
Mutual Funds
― Other Institutional Investors
99.99% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BGM FAQ
What was Qilian International Holding Group Limited’s price range in the past 12 months?
Qilian International Holding Group Limited lowest stock price was $2.70 and its highest was $14.78 in the past 12 months.
What is Qilian International Holding Group Limited’s market cap?
Qilian International Holding Group Limited’s market cap is $1.10B.
When is Qilian International Holding Group Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Qilian International Holding Group Limited’s earnings last quarter?
Qilian International Holding Group Limited released its earnings results on Feb 09, 2024. The company reported -$0.232 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.232.
Is Qilian International Holding Group Limited overvalued?
According to Wall Street analysts Qilian International Holding Group Limited’s price is currently Overvalued.
Does Qilian International Holding Group Limited pay dividends?
Qilian International Holding Group Limited pays a Notavailable dividend of $0.25 which represents an annual dividend yield of N/A. See more information on Qilian International Holding Group Limited dividends here
What is Qilian International Holding Group Limited’s EPS estimate?
Qilian International Holding Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qilian International Holding Group Limited have?
Qilian International Holding Group Limited has 77,222,140 shares outstanding.
What happened to Qilian International Holding Group Limited’s price movement after its last earnings report?
Qilian International Holding Group Limited reported an EPS of -$0.232 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.719%.
Which hedge fund is a major shareholder of Qilian International Holding Group Limited?
Currently, no hedge funds are holding shares in BGM
---
Qilian International Holding Group Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
229.08%
12-Months-Change
Fundamentals
Return on Equity
-3.37%
Trailing 12-Months
Asset Growth
3.41%
Trailing 12-Months
Company Description
Qilian International Holding Group Limited
BGM Group Ltd manufactures and distributes active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company provides licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It offers Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was formerly known as Qilian International Holding Group Limited and changed its name to BGM Group Ltd in October 2024. BGM Group Ltd was incorporated in 2019 and is based in Chengdu, the People's Republic of China.
---
Technical Analysis
---